In preliminary scientific studies in patients with stable chronic liver cirrhosis, no significant variations in ciprofloxacin pharmacokinetics are already noticed. The pharmacokinetics of ciprofloxacin in people with acute hepatic insufficiency, have not been analyzed. Insulin and specific oral d